Skip to Content
Merck
CN

P4739

Phosphate buffered saline

powder (dry milled), pH 7.3, with 5% nonfat milk

Synonym(s):

PBS

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12161503
NACRES:
NA.25
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

Phosphate buffered saline, with 5% nonfat milk, powder (dry milled), pH 7.3

Quality Level

form

powder (dry milled)

composition

nonfat dry milk , potassium chloride, 76.5% , potassium phosphate monobasic anhydrous, 0.3% , sodium chloride, 12.2% , sodium phosphate dibasic, 10.7%

pH

7.3

Application

Phosphate-buffered saline has been used to block the SARS-COV2 antigen during the preparation of ELISA plates.


Still not finding the right product?

Explore all of our products under Phosphate buffered saline


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

低风险生物材料

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Xiao Cui et al.
Cell biology international, 44(9), 1811-1819 (2020-05-07)
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that is caused by the interaction of genetic and environmental factors. Current studies have shown that Fc-receptor like-3 (FCRL3) is closely related to MS, but the specific role
he Protease Inhibitor 4-(2-Aminoethyl) Benzenesulfonyl Fluoride Covalently Modifies Human Plasma Proteins and Changes Protein Isoform Profiles
Mark Schuchard
Molecular and Cellular Proteomics, 3 (2004)
Beatriz del Rio et al.
Clinical and vaccine immunology : CVI, 15(9), 1429-1435 (2008-07-18)
Mucosal immunization is advantageous over other routes of antigen delivery because it can induce both mucosal and systemic immune responses. Our goal was to develop a mucosal delivery vehicle based on bacteria generally regarded as safe, such as Lactobacillus spp.



Global Trade Item Number

SKUGTIN
P4739-10PAK04061834375159